Neurogene (NGNE) Reports In-Line Q3 EPS

Neurogene (NASDAQ: NGNE) reported Q3 EPS of ($1.19), in-line with the analyst estimate of ($1.19).

For earnings history and earnings-related data on Neurogene (NGNE) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue